- Quest owns Photodynamic Therapy Technology and Bioceltran owns Protein Transduction Technology
- Quest and Bioceltran are Developing Skin penetrating Active Molecules for Cosmetic and Pharmaceutical Use
- Quest has worldwide (excluding South Korea) rights to Bioceltran PTD Technology and Products for certain indications
- Bioceltran has exclusive license to Quest’s Photodynamic Therapy Technology
- Quest is one of the major shareholders of Bioceltran